As of 4:03pm ET
| -0.08 / -0.12%|
Agilent Technologies, Inc. engages in the provision of core bio-analytical and electronic measurement solutions to the life sciences, chemical analysis, communications and electronics, diagnostics and genomics industries. It operates through the following segments: Life Sciences; Chemical Analysis; Diagnostics and Genomics; and Electronic Measurement. The Life Sciences segment provides application-focused solutions that include instruments, software, consumables and services that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. The Chemical Analysis segment manufactures gas chromatography mass spectrometry systems, inductively coupled plasma mass spectrometry instruments, atomic absorption instruments, inductively coupled plasma optical emission spectrometry instruments, molecular spectroscopy instruments, vacuum pumps and measurement technologies supports and services. The Diagnostics and Genomics segment provides solutions that include reagents, instruments, software and consumables that enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. The Electronic Measurement segment provides electronic measurement instruments and systems, software design tools and related services that are used in the design, development, manufacture, installation, deployment and operation of electronics equipment and microscopy products. The company was founded in 1999 and is headquartered in Santa Clara, CA.
|Michael R. McMullen||President, Chief Executive Officer & Director|
|Kristin Giffin||Vice President-Operations, Quality & Support|
|Didier Hirsch||Chief Financial Officer & Senior Vice President|
|Darlene J. S. Solomon||Chief Technology Officer & Senior Vice President|
|Richard A. Burdsall||Senior Vice President|